R J Plunkett1, A Lis, T A Barone, M D Fronckowiak, S J Greenberg. 1. Department of Neurosurgery, State University of New York at Buffalo, Veterans Administration Medical Center, and Roswell Park Cancer Institute, 14203, USA. rjp@pce.net
Abstract
OBJECT: The authors studied the effect of gender and hormonal status on survival in nude rats implanted with human glioblastoma multiforme (GBM) cell lines. METHODS: Nude rats received intracerebral implants of either wild-type U87MG cells or U87MG cells transfected with the gene for endothelin-1 (U87/ET-1). In the initial study, survival was compared in males and females for each of the two cell lines. The six second-phase study groups were composed of: 1) males; 2) females; 3) ovariectomized females; 4) sham ovariectomized females; 5) ovariectomized rats given 10 microg/day estradiol benzoate for 21 days; and 6) ovariectomized rats given 20 mg/kg/day progesterone for 21 days. All rats in the second phase were implanted with U87/ET-1 cells. Animals were killed when they exhibited initial signs of neurological deterioration. Female nude rats survived longer than male rats implanted with either U87 or U87/ET-1 cells. In the second phase, ovariectomized, male, and progesterone-treated rats died at approximately 19 days, whereas the female, sham-treated, and estrogen-treated animals died 23 to 25 days after tumor cell implantation. CONCLUSIONS: The authors demonstrate that female nude rats implanted with human GBM cells have a survival advantage over male rats and that estrogen provides the advantage.
OBJECT: The authors studied the effect of gender and hormonal status on survival in nude rats implanted with humanglioblastoma multiforme (GBM) cell lines. METHODS: Nude rats received intracerebral implants of either wild-type U87MG cells or U87MG cells transfected with the gene for endothelin-1 (U87/ET-1). In the initial study, survival was compared in males and females for each of the two cell lines. The six second-phase study groups were composed of: 1) males; 2) females; 3) ovariectomized females; 4) sham ovariectomized females; 5) ovariectomized rats given 10 microg/day estradiol benzoate for 21 days; and 6) ovariectomized rats given 20 mg/kg/day progesterone for 21 days. All rats in the second phase were implanted with U87/ET-1 cells. Animals were killed when they exhibited initial signs of neurological deterioration. Female nude rats survived longer than male rats implanted with either U87 or U87/ET-1 cells. In the second phase, ovariectomized, male, and progesterone-treated rats died at approximately 19 days, whereas the female, sham-treated, and estrogen-treated animals died 23 to 25 days after tumor cell implantation. CONCLUSIONS: The authors demonstrate that female nude rats implanted with human GBM cells have a survival advantage over male rats and that estrogen provides the advantage.
Authors: Geoffrey C Kabat; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin; Thomas E Rohan Journal: Int J Cancer Date: 2011-02-15 Impact factor: 7.396
Authors: Sophia S Wang; Patricia Hartge; Meredith Yeager; Tania Carreón; Avima M Ruder; Martha Linet; Peter D Inskip; Amanda Black; Ann W Hsing; Michael Alavanja; Laura Beane-Freeman; Mahboobeh Safaiean; Stephen J Chanock; Preetha Rajaraman Journal: Am J Epidemiol Date: 2011-09-13 Impact factor: 4.897
Authors: Martha J Felini; Andrew F Olshan; Jane C Schroeder; Susan E Carozza; Rei Miike; Terri Rice; Margaret Wrensch Journal: Cancer Causes Control Date: 2008-09-03 Impact factor: 2.506
Authors: T Hirai; R Murakami; H Nakamura; M Kitajima; H Fukuoka; A Sasao; M Akter; Y Hayashida; R Toya; N Oya; K Awai; K Iyama; J-i Kuratsu; Y Yamashita Journal: AJNR Am J Neuroradiol Date: 2008-06-12 Impact factor: 3.825